HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
1326studies shown
Showing 937-948 of 1,326
Drug study icon
CompletedNCT02905734

Nicotine Replacement Therapy in Nicotine-dependent Arrestees

Official study title

Nicotine Replacement Therapy in Nicotine-dependent Arrestees: a Monocentric Randomized Simple Blind Study

This study has finished and is no longer accepting participants.

In France
AddictionMedication studyAges 18–76
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Drug study icon
CompletedNCT05007028

Nitrous Oxide for Late-Life Depression - PROTO-BRAIN

What is this study about?

Researchers compared EMONO and placebo to find out how the approaches affected depression symptoms in older adults with depression.

This study has finished and is no longer accepting participants.

In France
DepressionMedication studyAges 60–90
Countries
France
Sponsor
University Hospital, Tours
Other study type icon
CompletedNCT03162380

Occupational Stress and Bipolarity

Official study title

Assessment of Occupational Stress and Well-being in French Patients Suffering From Bipolar Disorder

This study has finished and is no longer accepting participants.

In France
BipolarityObservational studyAges 18–65
Countries
France
Sponsor
University Hospital, Montpellier
Drug study icon
CompletedNCT00091650

Olanzapine in people with Borderline Personality Disorder

Official study title

Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder: A Randomized Flexible Dose Double-Blind Comparison With Placebo

This study has finished and is no longer accepting participants.

In France
Personality disordersMedication studyAges 15–65
Countries
France, United States, United Kingdom, + 6 others
Sponsor
Eli Lilly and Company
Drug study icon
CompletedNCT00320489

Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia

Official study title

A Randomized, Open-label Study Comparing the Effects of Olanzapine Pamoate Depot With Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia

This study has finished and is no longer accepting participants.

In France
SchizophreniaMedication studyAges 18–65
Countries
France, United States, Canada, + 8 others
Sponsor
Eli Lilly and Company
Other study type icon
CompletedNCT06809881

OLFACTION AND BIPOLAR DISODER

This study has finished and is no longer accepting participants.

In France
BipolarityInterventional studyAges 18–65
Countries
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.